Related Experiment Video
Updated: Jun 5, 2026
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Tumor immunosurveillance in human cancers
Bernhard Mlecnik1, Gabriela Bindea, Franck Pagès
1INSERM U872, Integrative Cancer Immunology Team, 15 rue de l'Ecole de Médecine, Paris 75006, France.
Cancer Metastasis Reviews
|January 21, 2011
Summary
The immune microenvironment of colorectal tumors is a crucial prognostic factor, surpassing traditional TNM staging for predicting patient survival. Understanding immune cell interactions offers new therapeutic targets for colorectal cancer.
Area of Science:
- Oncology
- Immunology
- Systems Biology
Background:
- Traditionally, the anatomic extent of tumor (TNM classification) has been the primary prognostic factor for colorectal cancer.
- Emerging evidence highlights the immune contexture of primary tumors as a critical determinant of patient survival.
Purpose of the Study:
- To investigate the prognostic significance of the tumor immune microenvironment in colorectal cancer.
- To explore tumoral and immunological markers for predicting patient outcomes and therapeutic targets.
Main Methods:
- Analysis of large cohorts of human cancers.
- Systems biology approaches to predict tumoral and immunological markers.
- Global analysis of the tumor microenvironment, focusing on immune cell characteristics and location.
Main Results:
- The nature, orientation, density, and location of adaptive immune cells within tumors significantly influence relapse risk.
- Immune cell density and location within the tumor provide prognostic value superior to TNM classification.
- Tumor invasion is statistically dependent on the host-immune reaction.
Conclusions:
- The strength of the host-immune reaction is a critical factor in colorectal cancer prognosis.
- Immune contexture offers a more powerful prognostic indicator than TNM staging.
- Understanding the immune microenvironment is essential for advancing cancer evolution insights and clinical practice.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...